Oct 15 (Reuters) - Abbott reported higher

quarterly revenue on Wednesday, driven by strong demand for its

medical devices including continuous glucose monitors and heart

devices.

Investor confidence in medical device makers has climbed in

recent quarters, underpinned by robust demand for surgical

procedures, particularly among older adults.

Total revenue rose 7.1% to $11.4 billion.

On an adjusted basis, third-quarter profit per share of

$1.30, in line with analyst's average estimate, according to

data compiled by LSEG.

The company now expects annual adjusted profit between $5.12

and $5.18 per share, compared to its previous range of $5.10 to

$5.20.

Its medical devices segment, which sells heart and diabetes

care devices, posted sales of $5.45 billion, beating estimates

of $5.34 billion.

(Reporting by Kamal Choudhury and Christy Santhosh in

Bengaluru; Editing by Sriraj Kalluvila)